drug

Management

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
PROCEDURE
Pre-approval / investigational in the US
Developed by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
PROCEDURE

Indications

Trials

2
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II
NCT00377117—Completed
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population
NCT00253240—Completed

KOLs & investigators

2
Stewart B Harris, MD MPH CCFP FACPM
David RS Haslam, MSc MD FRCPC

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
company
trial
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II
trial
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population
trial
indication
Schizophrenia
indication
Diabetes Mellitus
indication
Diabetes Mellitus
indication
Schizophrenia
indication
KOL
Stewart B Harris, MD MPH CCFP FACPM
KOL score —
person
David RS Haslam, MSc MD FRCPC
KOL score —
person